Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 201

1.

Ultrafast relaxation of photoexcited superfluid He nanodroplets.

Mudrich M, LaForge AC, Ciavardini A, O'Keeffe P, Callegari C, Coreno M, Demidovich A, Devetta M, Fraia MD, Drabbels M, Finetti P, Gessner O, Grazioli C, Hernando A, Neumark DM, Ovcharenko Y, Piseri P, Plekan O, Prince KC, Richter R, Ziemkiewicz MP, Möller T, Eloranta J, Pi M, Barranco M, Stienkemeier F.

Nat Commun. 2020 Jan 8;11(1):112. doi: 10.1038/s41467-019-13681-6.

2.

Overexpression of Annexin A1 Is an Independent Predictor of Longer Overall Survival in Epithelial Ovarian Cancer.

Manai M, Doghri R, Finetti P, Mrad K, Bouabsa R, Manai M, Birnbaum D, Bertucci F, Charfi L, Driss M.

In Vivo. 2020 Jan-Feb;34(1):177-184. doi: 10.21873/invivo.11759.

PMID:
31882477
3.

NOTCH and DNA repair pathways are more frequently targeted by genomic alterations in inflammatory than in non-inflammatory breast cancers.

Bertucci F, Rypens C, Finetti P, Guille A, Adelaïde J, Monneur A, Carbuccia N, Garnier S, Dirix P, Gonçalves A, Vermeulen P, Debeb BG, Wang X, Dirix L, Ueno NT, Viens P, Cristofanilli M, Chaffanet M, Birnbaum D, Van Laere S.

Mol Oncol. 2019 Dec 19. doi: 10.1002/1878-0261.12621. [Epub ahead of print]

4.

Comparative Experimental and Theoretical Study of the C and O K-Edge X-ray Absorption Spectroscopy in Three Highly Popular, Low Spin Organoiron Complexes: [Fe(CO)5], [(η5-C5H5)Fe(CO)(μ-CO)]2, and [(η5-C5H5)2Fe].

Carlotto S, Finetti P, de Simone M, Coreno M, Casella G, Sambi M, Casarin M.

Inorg Chem. 2019 Dec 16;58(24):16411-16423. doi: 10.1021/acs.inorgchem.9b02107. Epub 2019 Nov 22.

PMID:
31756086
5.

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma.

Billon E, Finetti P, Bertucci A, Niccoli P, Birnbaum D, Mamessier E, Bertucci F.

Oncoimmunology. 2019 Aug 28;8(11):e1655362. doi: 10.1080/2162402X.2019.1655362. eCollection 2019.

PMID:
31646101
6.

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.

Garciaz S, N'guyen Dasi L, Finetti P, Chevalier C, Vernerey J, Poplineau M, Platet N, Audebert S, Pophillat M, Camoin L, Bertucci F, Calmels B, Récher C, Birnbaum D, Chabannon C, Vey N, Duprez E.

Clin Epigenetics. 2019 Oct 12;11(1):141. doi: 10.1186/s13148-019-0738-6.

7.

A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells.

Arfaoui A, Rioualen C, Azzoni V, Pinna G, Finetti P, Wicinski J, Josselin E, Macario M, Castellano R, Léonard-Stumpf C, Bal A, Gros A, Lossy S, Kharrat M, Collette Y, Bertucci F, Birnbaum D, Douik H, Bidaut G, Charafe-Jauffret E, Ginestier C.

EMBO Mol Med. 2019 Oct;11(10):e9930. doi: 10.15252/emmm.201809930. Epub 2019 Sep 2.

8.

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers.

de Nonneville A, Finetti P, Adelaide J, Lambaudie É, Viens P, Gonçalves A, Birnbaum D, Mamessier E, Bertucci F.

Cancers (Basel). 2019 Aug 13;11(8). pii: E1158. doi: 10.3390/cancers11081158.

9.

Deep neural networks for classifying complex features in diffraction images.

Zimmermann J, Langbehn B, Cucini R, Di Fraia M, Finetti P, LaForge AC, Nishiyama T, Ovcharenko Y, Piseri P, Plekan O, Prince KC, Stienkemeier F, Ueda K, Callegari C, Möller T, Rupp D.

Phys Rev E. 2019 Jun;99(6-1):063309. doi: 10.1103/PhysRevE.99.063309.

PMID:
31330687
10.

Sensitive and easy screening for circulating tumor cells by flow cytometry.

Lopresti A, Malergue F, Bertucci F, Liberatoscioli ML, Garnier S, DaCosta Q, Finetti P, Gilabert M, Raoul JL, Birnbaum D, Acquaviva C, Mamessier E.

JCI Insight. 2019 Jun 13;5. pii: 128180. doi: 10.1172/jci.insight.128180.

11.

PARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target.

Bertucci F, Finetti P, Monneur A, Perrot D, Chevreau C, Le Cesne A, Blay JY, Mir O, Birnbaum D.

Mol Oncol. 2019 Jul;13(7):1577-1588. doi: 10.1002/1878-0261.12522. Epub 2019 Jun 7.

12.

A Comparison of DNA Mutation and Copy Number Profiles of Primary Breast Cancers and Paired Brain Metastases for Identifying Clinically Relevant Genetic Alterations in Brain Metastases.

Tyran M, Carbuccia N, Garnier S, Guille A, Adelaïde J, Finetti P, Toulzian J, Viens P, Tallet A, Goncalves A, Metellus P, Birnbaum D, Chaffanet M, Bertucci F.

Cancers (Basel). 2019 May 13;11(5). pii: E665. doi: 10.3390/cancers11050665.

13.

XPO1 Expression Is a Poor-Prognosis Marker in Pancreatic Adenocarcinoma.

Birnbaum DJ, Finetti P, Birnbaum D, Mamessier E, Bertucci F.

J Clin Med. 2019 Apr 30;8(5). pii: E596. doi: 10.3390/jcm8050596.

14.

Real-Time Dynamics of the Formation of Hydrated Electrons upon Irradiation of Water Clusters with Extreme Ultraviolet Light.

LaForge AC, Michiels R, Bohlen M, Callegari C, Clark A, von Conta A, Coreno M, Di Fraia M, Drabbels M, Huppert M, Finetti P, Ma J, Mudrich M, Oliver V, Plekan O, Prince KC, Shcherbinin M, Stranges S, Svoboda V, Wörner HJ, Stienkemeier F.

Phys Rev Lett. 2019 Apr 5;122(13):133001. doi: 10.1103/PhysRevLett.122.133001.

PMID:
31012607
15.

Comparative Experimental and Theoretical Study of the Fe L2,3-Edges X-ray Absorption Spectroscopy in Three Highly Popular, Low-Spin Organoiron Complexes: [Fe(CO)5], [(η5-C5H5)Fe(CO)(μ-CO)]2, and [(η5-C5H5)2Fe].

Carlotto S, Finetti P, de Simone M, Coreno M, Casella G, Sambi M, Casarin M.

Inorg Chem. 2019 May 6;58(9):5844-5857. doi: 10.1021/acs.inorgchem.9b00226. Epub 2019 Apr 18.

PMID:
30998004
16.

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer.

Daulat AM, Finetti P, Revinski D, Silveira Wagner M, Camoin L, Audebert S, Birnbaum D, Kodjabachian L, Borg JP, Bertucci F.

Br J Cancer. 2019 Apr;120(9):931-940. doi: 10.1038/s41416-019-0448-z. Epub 2019 Apr 11.

17.

Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors.

Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E.

Cancers (Basel). 2019 Apr 8;11(4). pii: E497. doi: 10.3390/cancers11040497.

18.

ProNGF increases breast tumor aggressiveness through functional association of TrkA with EphA2.

Lévêque R, Corbet C, Aubert L, Guilbert M, Lagadec C, Adriaenssens E, Duval J, Finetti P, Birnbaum D, Magné N, Chopin V, Bertucci F, Le Bourhis X, Toillon RA.

Cancer Lett. 2019 May 1;449:196-206. doi: 10.1016/j.canlet.2019.02.019. Epub 2019 Feb 13.

PMID:
30771434
19.

Inflammatory breast cancer in 210 patients: A retrospective study on epidemiological, anatomo-clinical features and therapeutic results.

Manai M, Finetti P, Mejri N, Athimni S, Birnbaum D, Bertucci F, Rahal K, Gamoudi A, Chaffanet M, Manai M, Boussen H.

Mol Clin Oncol. 2019 Feb;10(2):223-230. doi: 10.3892/mco.2018.1773. Epub 2018 Nov 26.

20.

Three-Dimensional Shapes of Spinning Helium Nanodroplets.

Langbehn B, Sander K, Ovcharenko Y, Peltz C, Clark A, Coreno M, Cucini R, Drabbels M, Finetti P, Di Fraia M, Giannessi L, Grazioli C, Iablonskyi D, LaForge AC, Nishiyama T, Oliver Álvarez de Lara V, Piseri P, Plekan O, Ueda K, Zimmermann J, Prince KC, Stienkemeier F, Callegari C, Fennel T, Rupp D, Möller T.

Phys Rev Lett. 2018 Dec 21;121(25):255301. doi: 10.1103/PhysRevLett.121.255301.

21.

Pathological grade-independent prediction of chemosensitivity by CINSARC should rehabilitate adjuvant chemotherapy in soft tissue sarcomas of any grade.

Bertucci F, Finetti P, Monneur A, Birnbaum D.

Ann Oncol. 2019 Feb 1;30(2):342-343. doi: 10.1093/annonc/mdy528. No abstract available.

PMID:
30535178
22.

Symmetry breakdown of electron emission in extreme ultraviolet photoionization of argon.

Ilchen M, Hartmann G, Gryzlova EV, Achner A, Allaria E, Beckmann A, Braune M, Buck J, Callegari C, Coffee RN, Cucini R, Danailov M, De Fanis A, Demidovich A, Ferrari E, Finetti P, Glaser L, Knie A, Lindahl AO, Plekan O, Mahne N, Mazza T, Raimondi L, Roussel E, Scholz F, Seltmann J, Shevchuk I, Svetina C, Walter P, Zangrando M, Viefhaus J, Grum-Grzhimailo AN, Meyer M.

Nat Commun. 2018 Nov 7;9(1):4659. doi: 10.1038/s41467-018-07152-7.

23.

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer.

Bertucci F, Finetti P, Simeone I, Hendrickx W, Wang E, Marincola FM, Viens P, Mamessier E, Ceccarelli M, Birnbaum D, Bedognetti D.

Br J Cancer. 2018 Nov;119(11):1383-1391. doi: 10.1038/s41416-018-0309-1. Epub 2018 Oct 24.

24.

The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin Signaling.

Lopez Almeida L, Sebbagh M, Bertucci F, Finetti P, Wicinski J, Marchetto S, Castellano R, Josselin E, Charafe-Jauffret E, Ginestier C, Borg JP, Santoni MJ.

Stem Cell Reports. 2018 Nov 13;11(5):1040-1050. doi: 10.1016/j.stemcr.2018.09.008. Epub 2018 Oct 18.

25.

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.

Guerin M, Gonçalves A, Toiron Y, Baudelet E, Pophillat M, Granjeaud S, Fourquet P, Jacot W, Tarpin C, Sabatier R, Agavnian E, Finetti P, Adelaide J, Birnbaum D, Ginestier C, Charafe-Jauffret E, Viens P, Bertucci F, Borg JP, Camoin L.

Oncotarget. 2018 Sep 18;9(73):33762-33777. doi: 10.18632/oncotarget.26031. eCollection 2018 Sep 18.

26.

Control of H_{2} Dissociative Ionization in the Nonlinear Regime Using Vacuum Ultraviolet Free-Electron Laser Pulses.

Holzmeier F, Bello RY, Hervé M, Achner A, Baumann TM, Meyer M, Finetti P, Di Fraia M, Gauthier D, Roussel E, Plekan O, Richter R, Prince KC, Callegari C, Bachau H, Palacios A, Martín F, Dowek D.

Phys Rev Lett. 2018 Sep 7;121(10):103002. doi: 10.1103/PhysRevLett.121.103002.

27.

CMTM6 stabilizes PD-L1 expression and refines its prognostic value in tumors.

Mamessier E, Birnbaum DJ, Finetti P, Birnbaum D, Bertucci F.

Ann Transl Med. 2018 Feb;6(3):54. doi: 10.21037/atm.2017.11.26. No abstract available.

28.

Molecular classification as prognostic factor and guide for treatment decision of pancreatic cancer.

Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E.

Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):248-255. doi: 10.1016/j.bbcan.2018.02.001. Epub 2018 Feb 28. Review.

PMID:
29499330
29.

Acetylacetone photodynamics at a seeded free-electron laser.

Squibb RJ, Sapunar M, Ponzi A, Richter R, Kivimäki A, Plekan O, Finetti P, Sisourat N, Zhaunerchyk V, Marchenko T, Journel L, Guillemin R, Cucini R, Coreno M, Grazioli C, Di Fraia M, Callegari C, Prince KC, Decleva P, Simon M, Eland JHD, Došlić N, Feifel R, Piancastelli MN.

Nat Commun. 2018 Jan 4;9(1):63. doi: 10.1038/s41467-017-02478-0.

30.

"Wnt/β-Catenin in GIST"-Letter.

Bertucci F, Finetti P, De Nonneville A, Birnbaum D.

Mol Cancer Ther. 2018 Jan;17(1):327-328. doi: 10.1158/1535-7163.MCT-17-0948.

31.

Stromal Expression of MARCKS Protein in Ovarian Carcinomas Has Unfavorable Prognostic Value.

Doghri R, Manai M, Finetti P, Driss M, Agavnian E, Lopez M, Elghardallou M, Charafe-Jauffret E, Manai M, Chaffanet M, Birnbaum D, Mrad K, Bertucci F.

Int J Mol Sci. 2017 Dec 23;19(1). pii: E41. doi: 10.3390/ijms19010041.

32.

Validation and comparison of the molecular classifications of pancreatic carcinomas.

Birnbaum DJ, Finetti P, Birnbaum D, Mamessier E, Bertucci F.

Mol Cancer. 2017 Nov 6;16(1):168. doi: 10.1186/s12943-017-0739-z.

33.

The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.

Bertucci F, De Nonneville A, Finetti P, Perrot D, Nilbert M, Italiano A, Le Cesne A, Skubitz KM, Blay JY, Birnbaum D.

Ann Oncol. 2018 Feb 1;29(2):459-465. doi: 10.1093/annonc/mdx699.

PMID:
29069276
34.

Similar response profile to neoadjuvant chemotherapy, but different survival, in inflammatory versus locally advanced breast cancers.

Monneur A, Goncalves A, Gilabert M, Finetti P, Tarpin C, Zemmour C, Extra JM, Tallet A, Lambaudie E, Jacquemier J, Houvenaeghel G, Boher JM, Viens P, Bertucci F.

Oncotarget. 2017 Jul 31;8(39):66019-66032. doi: 10.18632/oncotarget.19732. eCollection 2017 Sep 12.

35.

Wnt Signaling Inhibition Promotes Apoptosis in Sarcomas-Letter.

Bertucci F, Finetti P, Birnbaum D.

Mol Cancer Ther. 2017 Oct;16(10):2324. doi: 10.1158/1535-7163.MCT-17-0491. No abstract available.

36.

Observation and Control of Laser-Enabled Auger Decay.

Iablonskyi D, Ueda K, Ishikawa KL, Kheifets AS, Carpeggiani P, Reduzzi M, Ahmadi H, Comby A, Sansone G, Csizmadia T, Kuehn S, Ovcharenko E, Mazza T, Meyer M, Fischer A, Callegari C, Plekan O, Finetti P, Allaria E, Ferrari E, Roussel E, Gauthier D, Giannessi L, Prince KC.

Phys Rev Lett. 2017 Aug 18;119(7):073203. doi: 10.1103/PhysRevLett.119.073203. Epub 2017 Aug 14.

PMID:
28949652
37.

A 25-gene classifier predicts overall survival in resectable pancreatic cancer.

Birnbaum DJ, Finetti P, Lopresti A, Gilabert M, Poizat F, Raoul JL, Delpero JR, Moutardier V, Birnbaum D, Mamessier E, Bertucci F.

BMC Med. 2017 Sep 20;15(1):170. doi: 10.1186/s12916-017-0936-z.

38.

Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC).

Joglekar-Javadekar M, Van Laere S, Bourne M, Moalwi M, Finetti P, Vermeulen PB, Birnbaum D, Dirix LY, Ueno N, Carter M, Rains J, Ramachandran A, Bertucci F, van Golen KL.

Neoplasia. 2017 Jul;19(7):564-573. doi: 10.1016/j.neo.2017.03.002. Epub 2017 Jun 10.

39.

Impulsive laser-induced alignment of OCS molecules at FERMI.

Di Fraia M, Finetti P, Richter R, Prince KC, Wiese J, Devetta M, Negro M, Vozzi C, Ciriolo AG, Pusala A, Demidovich A, Danailov MB, Karamatskos ET, Trippel S, Küpper J, Callegari C.

Phys Chem Chem Phys. 2017 Aug 2;19(30):19733-19739. doi: 10.1039/c7cp01812f.

PMID:
28561126
40.

Erratum to: HDAC6 activity is a non-oncogene addiction hub for inflammatory breast cancers.

Putcha P, Yu J, Rodriguez-Barrueco R, Saucedo-Cuevas L, Villagrasa P, Murga-Penas E, Quayle SN, Yang M, Castro V, Llobet-Navas D, Birnbaum D, Finetti P, Woodward WA, Bertucci F, Alpaugh ML, Califano A, Silva J.

Breast Cancer Res. 2017 Apr 19;19(1):49. doi: 10.1186/s13058-017-0841-6. No abstract available.

41.

PDL1 expression is a poor-prognosis factor in soft-tissue sarcomas.

Bertucci F, Finetti P, Perrot D, Leroux A, Collin F, Le Cesne A, Coindre JM, Blay JY, Birnbaum D, Mamessier E.

Oncoimmunology. 2017 Feb 8;6(3):e1278100. doi: 10.1080/2162402X.2016.1278100. eCollection 2017.

42.

miR-424(322)/503 is a breast cancer tumor suppressor whose loss promotes resistance to chemotherapy.

Rodriguez-Barrueco R, Nekritz EA, Bertucci F, Yu J, Sanchez-Garcia F, Zeleke TZ, Gorbatenko A, Birnbaum D, Ezhkova E, Cordon-Cardo C, Finetti P, Llobet-Navas D, Silva JM.

Genes Dev. 2017 Mar 15;31(6):553-566. doi: 10.1101/gad.292318.116.

43.

A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.

Morel AP, Ginestier C, Pommier RM, Cabaud O, Ruiz E, Wicinski J, Devouassoux-Shisheboran M, Combaret V, Finetti P, Chassot C, Pinatel C, Fauvet F, Saintigny P, Thomas E, Moyret-Lalle C, Lachuer J, Despras E, Jauffret JL, Bertucci F, Guitton J, Wierinckx A, Wang Q, Radosevic-Robin N, Penault-Llorca F, Cox DG, Hollande F, Ansieau S, Caramel J, Birnbaum D, Vigneron AM, Tissier A, Charafe-Jauffret E, Puisieux A.

Nat Med. 2017 May;23(5):568-578. doi: 10.1038/nm.4323. Epub 2017 Apr 10.

PMID:
28394329
44.

Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis.

Hendrickx W, Simeone I, Anjum S, Mokrab Y, Bertucci F, Finetti P, Curigliano G, Seliger B, Cerulo L, Tomei S, Delogu LG, Maccalli C, Wang E, Miller LD, Marincola FM, Ceccarelli M, Bedognetti D.

Oncoimmunology. 2017 Feb 6;6(2):e1253654. doi: 10.1080/2162402X.2016.1253654. eCollection 2017.

45.

Prognostic Value of Molecular Subtypes in Pancreatic Cancer.

Bertucci F, Birnbaum DJ, Finetti P, Gilabert M, Poizat F, Raoul JL, Birnbaum D, Mamessier E.

Pancreas. 2017 Apr;46(4):e29-e31. doi: 10.1097/MPA.0000000000000787. No abstract available.

PMID:
28291163
46.

miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling.

El Helou R, Pinna G, Cabaud O, Wicinski J, Bhajun R, Guyon L, Rioualen C, Finetti P, Gros A, Mari B, Barbry P, Bertucci F, Bidaut G, Harel-Bellan A, Birnbaum D, Charafe-Jauffret E, Ginestier C.

Cell Rep. 2017 Feb 28;18(9):2256-2268. doi: 10.1016/j.celrep.2017.02.016.

47.

Time-Resolved Measurement of Interatomic Coulombic Decay Induced by Two-Photon Double Excitation of Ne_{2}.

Takanashi T, Golubev NV, Callegari C, Fukuzawa H, Motomura K, Iablonskyi D, Kumagai Y, Mondal S, Tachibana T, Nagaya K, Nishiyama T, Matsunami K, Johnsson P, Piseri P, Sansone G, Dubrouil A, Reduzzi M, Carpeggiani P, Vozzi C, Devetta M, Negro M, Faccialà D, Calegari F, Trabattoni A, Castrovilli MC, Ovcharenko Y, Mudrich M, Stienkemeier F, Coreno M, Alagia M, Schütte B, Berrah N, Plekan O, Finetti P, Spezzani C, Ferrari E, Allaria E, Penco G, Serpico C, De Ninno G, Diviacco B, Di Mitri S, Giannessi L, Jabbari G, Prince KC, Cederbaum LS, Demekhin PV, Kuleff AI, Ueda K.

Phys Rev Lett. 2017 Jan 20;118(3):033202. doi: 10.1103/PhysRevLett.118.033202. Epub 2017 Jan 19.

PMID:
28157370
48.

Circular Dichroism in Multiphoton Ionization of Resonantly Excited He^{+} Ions.

Ilchen M, Douguet N, Mazza T, Rafipoor AJ, Callegari C, Finetti P, Plekan O, Prince KC, Demidovich A, Grazioli C, Avaldi L, Bolognesi P, Coreno M, Di Fraia M, Devetta M, Ovcharenko Y, Düsterer S, Ueda K, Bartschat K, Grum-Grzhimailo AN, Bozhevolnov AV, Kazansky AK, Kabachnik NM, Meyer M.

Phys Rev Lett. 2017 Jan 6;118(1):013002. doi: 10.1103/PhysRevLett.118.013002. Epub 2017 Jan 5.

PMID:
28106422
49.

Slow Interatomic Coulombic Decay of Multiply Excited Neon Clusters.

Iablonskyi D, Nagaya K, Fukuzawa H, Motomura K, Kumagai Y, Mondal S, Tachibana T, Takanashi T, Nishiyama T, Matsunami K, Johnsson P, Piseri P, Sansone G, Dubrouil A, Reduzzi M, Carpeggiani P, Vozzi C, Devetta M, Negro M, Calegari F, Trabattoni A, Castrovilli MC, Faccialà D, Ovcharenko Y, Möller T, Mudrich M, Stienkemeier F, Coreno M, Alagia M, Schütte B, Berrah N, Kuleff AI, Jabbari G, Callegari C, Plekan O, Finetti P, Spezzani C, Ferrari E, Allaria E, Penco G, Serpico C, De Ninno G, Nikolov I, Diviacco B, Di Mitri S, Giannessi L, Prince KC, Ueda K.

Phys Rev Lett. 2016 Dec 30;117(27):276806. doi: 10.1103/PhysRevLett.117.276806. Epub 2016 Dec 30.

50.

MARCKS protein overexpression in inflammatory breast cancer.

Manai M, Thomassin-Piana J, Gamoudi A, Finetti P, Lopez M, Eghozzi R, Ayadi S, Lamine OB, Manai M, Rahal K, Charafe-Jauffret E, Jacquemier J, Viens P, Birnbaum D, Boussen H, Chaffanet M, Bertucci F.

Oncotarget. 2017 Jan 24;8(4):6246-6257. doi: 10.18632/oncotarget.14057.

Supplemental Content

Loading ...
Support Center